Loading...
Cisplatin and TRAIL enhance breast cancer stem cell death
Triple negative breast cancer (TNBC) has increased recurrence and poor survival, despite a high response rate to neoadjuvant chemotherapy. The aim of this study was to determine whether current drug treatment(s) eliminates bulk of tumor cells, but it has a minimal effect on cancer stem cells (CSCs)...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3889134/ https://ncbi.nlm.nih.gov/pubmed/21687939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2011.1085 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|